About halfrx

halfrx compares US weight-loss telehealth providers and GLP-1 medications on one number: what you pay once you are on a maintenance dose. That is rarely the figure in the advert.

Why the site exists

The category advertises in a way that is technically true and practically misleading. Programs quote a membership fee and leave the medication out. Manufacturers quote a starting dose the label says is not for maintenance. One major program prices its top doses $250 below the real figure unless you refill within 45 days, and counts a month as 28 days so a year takes thirteen payments. None of that is hidden — it is in the footnotes, and nobody reads footnotes while comparing eleven tabs.

GoodRx compares prices of drugs rather than the companies selling access to them, and since launching its own weight-loss subscription it also competes with the programs it lists. Most of the remaining comparison sites are paid per signup and quote the cheapest number a provider will let them print.

How it is funded

No link on halfrx earns a commission at present, and nothing else pays either: no provider pays for placement, and none has ever seen a review before publication. Commission links are the one income the site is built to take, and each will be labeled where it appears. That is precisely why the score is a published formula instead of an opinion — you do not have to trust our motives, you can recompute the number.

One rule sits above the commission and is enforced in code rather than promised: a company carrying any of the 4 flags that cap a score at 4.5 — FTC lawsuit, state action, BBB rating F, FDA warning letter — gets no commission link at all. Its card still links to it, because you may want to go there anyway — but halfrx is not paid for that click, since being paid to send people to one would be earning from exactly the conflict this site was built to point out in other comparison sites. Every paid link says “paid link” beside itself, not only in a footnote. Which links earn today, and the rules in full, are in the affiliate disclosure.

What we promise, and how to check it

A pledge nobody can test is marketing. Each of these has something you can open.

• No provider can buy a position, a score, or a flag removed.

  The score is arithmetic over the facts recorded for each provider and drug, published in full at /method. Recompute it yourself from any card and you get the number we show. Affiliate status is not an input to any component.

  Check it →

• Every price carries the date it was verified.

  A card with no verified price shows no verified figure — where a seller publishes only parts of a price, their sum is shown marked as an estimate — and a card with no price at all scores zero on cost. The same rule reaches our chat, our machine-readable feed and the CSV files anyone can download: an unverified price is an empty cell there, never a number we inferred.

  Check it →

• We quote what you pay once titrated, not the headline.

  Introductory rates and starting doses earn no points. Where a provider publishes only titration pricing, cost scores zero — a maintenance price nobody publishes is not a cheap price.

  Check it →

• Lawsuits and complaint records appear on the card, not in a footnote.

  Any of these caps a score at 4.5 out of 10 whatever else it earns: FTC lawsuit, state action, BBB rating F, FDA warning letter. The flag shows on the tile before you click.

  Check it →

• When we get something wrong we publish the correction.

  Every changed figure is listed with what it used to say and why it was wrong.

  Check it →

Where we are weak

Several providers block automated reading of their own pricing pages, so those cards are re-checked by hand and go stale between checks. Cards resting only on third-party trackers rather than on a manufacturer, a regulator or a journal say so in an amber box. We would rather print the weakness than average it away.

Right now: 19 of 43 cards carry a verified all-in price at the maintenance dose, 10 more show only a range, a starting price or an estimate, and 12 were read on a stated date and found to publish no price at all. The most recent check was 2026-09-22, and 272 corrections have been published.

Not medical advice

halfrx compares products and prices. It does not recommend doses, tell anyone to start or stop a medication, or interpret symptoms. Those are decisions for a prescriber who can examine you.

Contact

Corrections: the box at the foot of every page, or corrections@halfrx.com. Anything else: hello@halfrx.com.